These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
62 related items for PubMed ID: 990132
1. Lymphocytic infiltration in endometrial adenocarcinoma. Correlation with histologic differentiation, clinical staging and prognosis. Menczer J, Horowitz A, Ezra D, Czernobilsky B. Isr J Med Sci; 1976 Oct; 12(10):1148-52. PubMed ID: 990132 [Abstract] [Full Text] [Related]
3. [Histology and prognosis of endometrial carcinoma]. Sakamoto A, Hirai Y, Yamauchi K, Kitagawa T, Sugano H, Masubuchi K, Hasumi K. Gan No Rinsho; 1987 Dec; 33(15):1897-900. PubMed ID: 3430742 [Abstract] [Full Text] [Related]
4. The presence of tumor-infiltrating FOXP3+ lymphocytes correlates with intratumoral angiogenesis in endometrial cancer. Giatromanolaki A, Bates GJ, Koukourakis MI, Sivridis E, Gatter KC, Harris AL, Banham AH. Gynecol Oncol; 2008 Aug; 110(2):216-21. PubMed ID: 18533240 [Abstract] [Full Text] [Related]
8. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma. Nola M, Jukić S, Ilić-Forko J, Babić D, Uzarević B, Petrovecki M, Suchanek E, Skrablin S, Dotlić S, Marusić M. Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103 [Abstract] [Full Text] [Related]
9. Endocervical-type epithelium in endometrial carcinoma: a report of 10 cases with emphasis on histochemical methods for differential diagnosis. Czernobilsky B, Katz Z, Lancet M, Gaton E. Am J Surg Pathol; 1980 Oct; 4(5):481-9. PubMed ID: 7435776 [Abstract] [Full Text] [Related]
10. [Results of assays of estrogen, progesterone and androgen receptors in stage I and II adenocarcinoma of the endometrium]. Cormier P, Floquet A, Wafflart J, Coindre JM, Bonichon F, Marée D. Rev Fr Gynecol Obstet; 1991 Oct; 86(7-9):491-4. PubMed ID: 1754802 [Abstract] [Full Text] [Related]
11. Morphometric analysis of endometrial adenocarcinoma: 1. Does architectural dedifferentiation accompany deep invasion by endometrial adenocarcinoma? Zaino RJ, Laskaris A, Whitney C, Sharkey FE. Int J Gynecol Pathol; 1987 Oct; 6(1):12-9. PubMed ID: 3570628 [Abstract] [Full Text] [Related]
12. Morphometric analysis of endometrial adenocarcinoma: 2. A comparison of architectural differentiation determined morphometrically with subjective grading. Zaino RJ, Laskaris A, Whitney C, Sharkey FE. Int J Gynecol Pathol; 1987 Oct; 6(1):20-8. PubMed ID: 3570629 [Abstract] [Full Text] [Related]
17. [Prognostic significance of the length of the uterus, depth of infiltration and grading of endometrium cancer]. Elling D, Schildhaus I, Götze W, Bartel U. Zentralbl Gynakol; 1990 Oct; 112(2):75-9. PubMed ID: 2316298 [Abstract] [Full Text] [Related]
18. Cervicovaginal cytology in uterine adenocarcinoma and adenosquamous carcinoma. Comparison of cytologic and histologic findings. Costa MJ, Kenny MB, Naib ZM. Acta Cytol; 1991 Oct; 35(1):127-34. PubMed ID: 1994621 [Abstract] [Full Text] [Related]
19. Presence of an estrogen-regulated protein in endometrial cancer. Sledge GW, Ramzy I, Dressler LG, Dorr FA, Adams DJ, McGuire WL. Obstet Gynecol; 1985 Sep; 66(3):423-7. PubMed ID: 3895080 [Abstract] [Full Text] [Related]